|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,413,000 |
Market
Cap: |
10.56(B) |
Last
Volume: |
456,301 |
Avg
Vol: |
504,733 |
52
Week Range: |
$114.17 - $208.42 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$238,260 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
25,597 |
25,597 |
30,235 |
146,471 |
Total Sell Value |
$5,039,534 |
$5,039,534 |
$5,742,535 |
$29,817,809 |
Total People Sold |
4 |
4 |
5 |
6 |
Total Sell Transactions |
4 |
4 |
6 |
17 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Snodgres Jon |
Chief Financial Officer |
|
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,922 |
26,821 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2019-02-28 |
4 |
S |
$59.01 |
$441,100 |
D/D |
(7,475) |
242,657 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
22,681 |
250,132 |
|
- |
|
Kuriyel Ralf |
Senior VP, R&D |
|
2018-12-18 |
4 |
S |
$54.44 |
$16,931 |
D/D |
(311) |
12,294 |
|
- |
|
Snodgres Jon |
CFO |
|
2018-11-26 |
4 |
AS |
$63.49 |
$2,015,915 |
D/D |
(31,753) |
20,899 |
|
- |
|
Snodgres Jon |
CFO |
|
2018-11-26 |
4 |
OE |
$24.50 |
$861,132 |
D/D |
31,753 |
52,652 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2018-11-05 |
4 |
S |
$65.75 |
$115,920 |
D/D |
(1,763) |
3,225 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2018-09-10 |
4 |
AS |
$57.71 |
$1,590,809 |
D/D |
(27,566) |
227,451 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2018-09-10 |
4 |
OE |
$16.55 |
$196,498 |
D/D |
11,873 |
255,017 |
|
- |
|
Barthelemy Nicholas |
Director |
|
2018-08-29 |
4 |
S |
$54.44 |
$358,196 |
D/D |
(6,580) |
4,186 |
|
- |
|
Barthelemy Nicholas |
Director |
|
2018-08-29 |
4 |
OE |
$38.76 |
$176,392 |
D/D |
4,426 |
10,766 |
|
- |
|
Snodgres Jon |
CFO |
|
2018-08-28 |
4 |
S |
$52.79 |
$763,359 |
D/D |
(14,460) |
20,899 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2018-08-22 |
4 |
S |
$51.44 |
$121,698 |
D/D |
(2,366) |
4,988 |
|
- |
|
Eddleman Roy T |
10% Owner |
|
2018-08-09 |
4 |
S |
$49.54 |
$5,760,536 |
I/I |
(116,073) |
370,000 |
|
- |
|
Eddleman Roy T |
10% Owner |
|
2018-08-08 |
4 |
S |
$49.05 |
$233,970 |
I/I |
(4,770) |
409,215 |
|
- |
|
Eddleman Roy T |
10% Owner |
|
2018-08-07 |
4 |
S |
$49.05 |
$785,577 |
D/D |
(16,015) |
413,985 |
|
- |
|
Eddleman Roy T |
10% Owner |
|
2018-08-06 |
4 |
S |
$49.05 |
$1,625,599 |
I/I |
(33,142) |
796,858 |
|
- |
|
Snodgres Jon |
CFO |
|
2018-07-18 |
4 |
D |
$47.91 |
$14,134 |
D/D |
(295) |
35,359 |
|
- |
|
Eddleman Roy T |
10% Owner |
|
2018-06-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
22,530 |
2,903,446 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2018-06-06 |
4 |
S |
$44.31 |
$85,606 |
D/D |
(1,932) |
7,354 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2018-05-21 |
4 |
AS |
$42.53 |
$691,016 |
D/D |
(16,249) |
243,144 |
|
- |
|
Eddleman Roy T |
10% Owner |
|
2018-05-16 |
4 |
S |
$42.07 |
$5,000,020 |
I/I |
(118,850) |
2,925,976 |
|
- |
|
Muir Glenn P |
Director |
|
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,486 |
4,455 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,486 |
9,286 |
|
- |
|
Dawes Karen A |
Director |
|
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,080 |
97,037 |
|
- |
|
638 Records found
|
|
Page 13 of 26 |
|
|